Christos Toumpanakis Selected Research

Pancreatitis

5/2002

Changes of plasma levels of gastrointestinal peptides over the course of acute pancreatitis. Any significance for the pathophysiology and treatment of acute pancreatitis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christos Toumpanakis Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 03/2007
19	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2022 - 02/2013
11	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2007
8	Carcinoid Heart Disease 09/2021 - 02/2008
8	Carcinoid Tumor (Carcinoid) 01/2021 - 03/2007
6	Disease Progression 01/2021 - 01/2009
3	Fibrosis (Cirrhosis) 01/2021 - 12/2017
2	Multiple Endocrine Neoplasia Type 1 01/2022 - 01/2016
2	Neuroendocrine Carcinoma 03/2021 - 01/2020
2	Carcinogenesis 01/2021 - 01/2016
2	Thrombosis (Thrombus) 01/2021 - 01/2014
2	Infections 01/2021 - 01/2003
1	Chronic Renal Insufficiency 10/2022
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2022
1	Heart Failure 06/2021
1	Intestinal Failure 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Vipoma (WDHA) 01/2019
1	Paraganglioma (Paragangliomas) 03/2017
1	Adenocarcinoma 03/2015
1	Nausea 01/2015
1	Hyperglycemia 01/2015
1	Fatigue 01/2015
1	Breast Neoplasms (Breast Cancer) 07/2014
1	Flushing 04/2011
1	Necrosis 01/2011
1	Latent Tuberculosis 01/2011
1	Tuberculosis (Tuberculoses) 01/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2008
1	Systemic Scleroderma (Systemic Sclerosis) 06/2007
1	Intestinal Diseases (Diseases, Intestinal) 06/2007
1	Inflammation (Inflammations) 05/2002
1	Pancreatitis 05/2002

Drug/Important Bio-Agent (IBA)

7	Radioisotopes (Radionuclides)IBA 10/2022 - 05/2008
7	Octreotide (Sandostatin)FDA LinkGeneric 01/2021 - 05/2002
7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 07/2009
6	Peptide Receptors (Peptide Receptor)IBA 10/2022 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2008
5	gallium Ga 68 dotatateIBA 01/2022 - 01/2011
5	Serotonin (5 Hydroxytryptamine)IBA 06/2021 - 02/2008
5	Chromogranin AIBA 03/2018 - 03/2007
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 01/2011
3	lanreotide (Somatuline)FDA Link 01/2021 - 01/2017
3	Gallium-68IBA 03/2018 - 01/2010
3	AcidsIBA 01/2018 - 03/2007
2	Biological ProductsIBA 01/2022 - 12/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 10/2008
2	OMS 2017IBA 01/2020 - 01/2018
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2019 - 05/2002
2	Peptides (Polypeptides)IBA 12/2017 - 05/2002
2	pasireotideIBA 01/2015 - 05/2008
2	Parathyroid Hormone-Related ProteinIBA 07/2014 - 01/2009
2	Hormones (Hormone)IBA 07/2014 - 02/2008
2	Fluorouracil (Carac)FDA LinkGeneric 03/2007 - 03/2007
2	Streptozocin (Streptozotocin)FDA Link 03/2007 - 03/2007
1	lutetium Lu 177 dotatateIBA 10/2022
1	ParaffinIBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	Formaldehyde (Formol)FDA Link 11/2021
1	PlatinumIBA 03/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	IntegrinsIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2017
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2016
1	Dihydrotachysterol (AT 10)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2015
1	Interferon-alpha (Interferon Alfa)IBA 11/2014
1	Capsules (Microcapsules)IBA 01/2014
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2014
1	Hydroxyindoleacetic AcidIBA 04/2011
1	InterferonsIBA 01/2011
1	Somatostatin Receptors (Somatostatin Receptor)IBA 05/2008
1	pentetreotide (OctreoScan)FDA Link 05/2008
1	Etoposide (VP 16)FDA LinkGeneric 03/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2007
1	Cisplatin (Platino)FDA LinkGeneric 03/2007
1	EndotoxinsIBA 01/2003
1	Glucagon (Glukagon)FDA Link 05/2002
1	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 05/2002
1	NeurotensinIBA 05/2002
1	GastrinsIBA 05/2002
1	Ranitidine (Zantac)FDA LinkGeneric 05/2002

Therapy/Procedure

18	Therapeutics 10/2022 - 05/2008
7	Drug Therapy (Chemotherapy) 06/2021 - 03/2007
2	Molecular Targeted Therapy 01/2021 - 04/2018
2	Colectomy 01/2019 - 03/2007
1	Immunotherapy 01/2022
1	Pancreatectomy 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 11/2021
1	Catheters 01/2021
1	Total Parenteral Nutrition 01/2021
1	Home Total Parenteral Nutrition 01/2021
1	Retreatment 11/2018
1	Appendectomy 01/2018
1	Conservative Treatment 01/2016
1	Liver Transplantation 07/2014
1	Radiotherapy 07/2014
1	Combination Drug Therapy (Combination Chemotherapy) 03/2007